Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determination of the elimination half-life of fibroblast growth factor-23.
Khosravi A, Cutler CM, Kelly MH, Chang R, Royal RE, Sherry RM, Wodajo FM, Fedarko NS, Collins MT. Khosravi A, et al. Among authors: fedarko ns. J Clin Endocrinol Metab. 2007 Jun;92(6):2374-7. doi: 10.1210/jc.2006-2865. Epub 2007 Mar 20. J Clin Endocrinol Metab. 2007. PMID: 17374707
Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
Collins MT, Lindsay JR, Jain A, Kelly MH, Cutler CM, Weinstein LS, Liu J, Fedarko NS, Winer KK. Collins MT, et al. Among authors: fedarko ns. J Bone Miner Res. 2005 Nov;20(11):1944-50. doi: 10.1359/JBMR.050718. Epub 2005 Jul 18. J Bone Miner Res. 2005. PMID: 16234967 Free article.
The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
Garringer HJ, Fisher C, Larsson TE, Davis SI, Koller DL, Cullen MJ, Draman MS, Conlon N, Jain A, Fedarko NS, Dasgupta B, White KE. Garringer HJ, et al. Among authors: fedarko ns. J Clin Endocrinol Metab. 2006 Oct;91(10):4037-42. doi: 10.1210/jc.2006-0305. Epub 2006 Jul 25. J Clin Endocrinol Metab. 2006. PMID: 16868048
Impact on bone of an estrogen receptor-alpha gene loss of function mutation.
Smith EP, Specker B, Bachrach BE, Kimbro KS, Li XJ, Young MF, Fedarko NS, Abuzzahab MJ, Frank GR, Cohen RM, Lubahn DB, Korach KS. Smith EP, et al. Among authors: fedarko ns. J Clin Endocrinol Metab. 2008 Aug;93(8):3088-96. doi: 10.1210/jc.2007-2397. Epub 2008 May 27. J Clin Endocrinol Metab. 2008. PMID: 18505767 Free PMC article.
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.
Ono M, Inkson CA, Sonn R, Kilts TM, de Castro LF, Maeda A, Fisher LW, Robey PG, Berendsen AD, Li L, McCartney-Francis N, Brown AC, Crawford NP, Molinolo A, Jain A, Fedarko NS, Young MF. Ono M, et al. Among authors: fedarko ns. PLoS One. 2013 Aug 14;8(8):e71709. doi: 10.1371/journal.pone.0071709. eCollection 2013. PLoS One. 2013. PMID: 23977121 Free PMC article.
Receptor tyrosine kinase expression in human bone marrow stromal cells.
Satomura K, Derubeis AR, Fedarko NS, Ibaraki-O'Connor K, Kuznetsov SA, Rowe DW, Young MF, Gehron Robey P. Satomura K, et al. Among authors: fedarko ns. J Cell Physiol. 1998 Dec;177(3):426-38. doi: 10.1002/(SICI)1097-4652(199812)177:3<426::AID-JCP6>3.0.CO;2-F. J Cell Physiol. 1998. PMID: 9808151
98 results